Philips to shut down Respironics facility in Kennesaw, affecting hundreds

Philips Respironics makes sleep and respiratory products and services for managing sleep apnea, oxygen therapy, noninvasive ventilation and respiratory drug therapy.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news

Related Links:

(MedPage Today) -- Analysis suggests that treatment of moderate-to-severe sleep apnea may help improve blood pressure control in high-risk group
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
AbstractObjectiveAirway inflammation plays an important role in obstructive sleep apnea (OSA); exhaled nitric oxide is regarded as a noninvasive marker of airway inflammation. The aim of this study was to evaluate fractional exhaled nitric oxide (FeNO) and nasal nitric oxide (nNO) in patients with OSA.MethodsSeventy-five patients with OSA and 30 health controls were enrolled in this study. FeNO and nNO were measured before and after sleep. Nasal lavage was performed in 31 non-smoking individuals immediately after NO measurement in the morning. The sample of nasal lavage was taken for cell classification and analyzing inter...
Source: Sleep and Breathing - Category: Respiratory Medicine Source Type: research
Untreated sleep apnea makes black people twice as likely to develop uncontrolled blood pressure, a study says.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
(MedPage Today) -- " Under-recognized " risk factor in African-Americans
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news
Condition:   Sleep Apnea Intervention:   Device: Respiratory polygraphy Sponsor:   Seoul National University Hospital Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
MONDAY, Dec. 10, 2018 (American Heart Association) -- Black adults with high blood pressure that defies standard prescription treatments might want to get screened for sleep apnea, new research suggests. Moderate or severe sleep apnea -- in which a...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Treatment of sleep disorder might help improve blood pressure control in this high-risk group.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
In this study, we sought to develop, implement, and evaluate the effectiveness of an electronic health record (EHR) alert to screen for OSA in patients with epilepsy. Methods A 3-month retrospective chart review was conducted of all patients with epilepsy>18 years of age who were evaluated in our epilepsy clinics prior to the intervention. An assessment for obstructive sleep apnea (AOSA) consisting of 12 recognized risk factors for OSA was subsequently developed and embedded in the EHR. The AOSA was utilized for a 3-month period. Patients identified with 2 or more risk factors were referred for polysomnography. A compa...
Source: Neurology Clinical Practice - Category: Neurology Authors: Tags: All Clinical Neurology, Sleep apnea, Electronic medical records, All Epilepsy/Seizures Research Source Type: research
Background: Obstructive sleep apnea (OSA) is a highly prevalent and consequential sleep disorder in older adults. Untreated moderate to severe OSA substantially increases the risk for hypertension and cardiovascular disease (CVD), which can be attributed to the accelerated progression of atherosclerosis and endothelial dysfunction. Objective: The aim of this study was to identify factors that can function as correlates of endothelial function in older adults with untreated, moderate to severe OSA and CVD or CVD risk factors. Methods: A subsample (N = 126) of adults aged 65 years and older from the HeartBEAT study w...
Source: Journal of Cardiovascular Nursing - Category: Nursing Tags: Feature Article/Online Only Source Type: research
Continuous positive airway pressure (CPAP) is the mainstay therapy for patients with obstructive sleep apnea (OSA) however compliance with CPAP is variable. Nasal ailments, such as nasal congestion are frequently mentioned as a cause for CPAP non-compliance, and potentially could be addressed prior to CPAP initiation, however, no specific criteria or recommendations for the evaluation and management of these patients exist. The aim of this retrospective study is to evaluate the effects of nasal anatomic features and disease on adherence to CPAP therapy for patients with OSA and determine the indications for pre-CPAP nasal ...
Source: Auris, Nasus, Larynx - Category: ENT & OMF Authors: Source Type: research
More News: Health Management | Pharmaceuticals | Respiratory Medicine | Sleep Apnea | Sleep Disorders | Sleep Medicine